 |
 |
|
|
|  PubMed
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
15 June 1993 | Volume 118 Issue 12 | Pages 913-919
Objective: To study the risk for human immunodeficiency virus (HIV) infection and the patterns of use and associated toxicity of zidovudine among health care workers after an occupational exposure to HIV.
Design: An ongoing, prospective surveillance project conducted by the Centers for Disease Control and Prevention.
Participants: Exposed workers voluntarily reported by 312 U.S. health care facilities from August 1983 to June 1992.
Results: Four of 1103 enrolled workers with percutaneous exposure to HIV-infected blood seroconverted (HIV seroconversion rate, 0.36%; upper limit of the 95% CI, 0.83%); no enrolled workers with mucous membrane (n = 75) or skin (n = 67) contact seroconverted. During October 1988 to June 1992, 31% of 848 enrolled workers used zidovudine after exposure; this proportion increased from 5% during October through December 1988 to 43% during January through June 1992. Despite using zidovudine after exposure, one worker became infected with a strain of HIV that was apparently sensitive to zidovudine. Adverse symptoms, most commonly nausea, malaise or fatigue, and headache, were reported by 75% of workers using zidovudine; 31% of workers did not complete planned courses of zidovudine because of adverse events.
Conclusions: The risk for HIV seroconversion after percutaneous exposure to HIV-infected blood is 0.36%, which is similar to previous estimates. Zidovudine is used after exposure by a sizable proportion of health care workers enrolled in the project despite frequent, minor, associated symptoms. Documented failures of postexposure zidovudine prophylaxis, including in one worker enrolled in this study, indicate that if zidovudine is protective, any protection afforded is not absolute. Postexposure zidovudine, if used, requires careful consideration of possible risks and benefits.
Author and Article Information
From the Hospital Infections Program and the Division of HIV/AIDS, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia. For the CDC Cooperative Needlestick Surveillance Group.
ARTICLE
Surveillance of HIV Infection and Zidovudine Use among Health Care Workers after Occupational Exposure to HIV-Infected Blood
For members of the surveillance group, see the Appendix.
Requests for Reprints: David M. Bell, MD, Hospital Infections Program, CDC, Mailstop A-07, Atlanta, GA 30333.
Acknowledgments: The authors thank Drs. William J. Martone, Eugene McCray, Ida M. Onorato, and Steven L. Solomon for their work in establishing this surveillance system; Dr. Adelisa L. Panlilio for epidemiologic assistance; and Dr. Mary E. Chamberland for review of this manuscript.
CiteULike 
Complore 
Connotea 
Del.icio.us 
Digg 
Facebook 
Reddit 
Technorati 
Twitter What's this?
Related articles in Annals:
This article has been cited by other articles:
|
|
 |
|
  C. Scully and J.S. Greenspan Human Immunodeficiency Virus (HIV) Transmission in Dentistry Journal of Dental Research, September 1, 2006; 85(9): 794 - 800. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N Makwana and F A I Riordan Prospective study of community needlestick injuries Arch. Dis. Child., May 1, 2005; 90(5): 523 - 524. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. L. Havens and Committee on Pediatric AIDS Postexposure Prophylaxis in Children and Adolescents for Nonoccupational Exposure to Human Immunodeficiency Virus Pediatrics, June 1, 2003; 111(6): 1475 - 1489. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J L Burton Health and safety at necropsy J. Clin. Pathol., April 1, 2003; 56(4): 254 - 260. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. C. Merchant and R. Keshavarz Human Immunodeficiency Virus Postexposure Prophylaxis for Adolescents and Children Pediatrics, August 1, 2001; 108 (2): e38 - e38. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. E. Babl, E. R. Cooper, B. Kastner, and S. Kharasch Prophylaxis Against Possible Human Immunodeficiency Virus Exposure After Nonoccupational Needlestick Injuries or Sexual Assaults in Children and Adolescents Arch Pediatr Adolesc Med, June 1, 2001; 155(6): 680 - 682. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. SHAPIRO, G. B. POTT, and A. H. RALSTON Alpha-1-antitrypsin inhibits human immunodeficiency virus type 1 FASEB J, January 1, 2001; 15(1): 115 - 122. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Radecki, A. Abbott, and L. Eloi Occupational Human Immunodeficiency Virus Exposure Among Residents and Medical Students: An Analysis of 5-Year Follow-up Data Arch Intern Med, November 13, 2000; 160(20): 3107 - 3111. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Q. Meng, A. J. Grosovsky, X. Shi, and V. E. Walker Mutagenicity and loss of heterozygosity at the APRT locus in human lymphoblastoid cells exposed to 3'-azido-3'-deoxythymidine Mutagenesis, September 1, 2000; 15(5): 405 - 410. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Robicsek, A. A. Fokin, T. N. Masters, and J. W. Cook Inhibition of needlestick-induced simulated viremia by local measures Ann. Thorac. Surg., July 1, 2000; 70(1): 229 - 233. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. M. Jochimsen, C.-C. Luo, J. F. Beltrami, R. A. Respess, C. A. Schable, and D. M. Cardo Investigations of Possible Failures of Postexposure Prophylaxis Following Occupational Exposures to Human Immunodeficiency Virus Arch Intern Med, October 25, 1999; 159(19): 2361 - 2363. [Full Text] [PDF]
|
|
|
|
 |
|
 S. M. Blake, R. A. Windsor, D. K. Lohrmann, N. Gay, R. Ledsky, A. Richman, S. B. Jones, and S. W. Banspach Factors Associated with Occupational Exposure and Compliance with Universal Precautions in an Urban School District Health Educ Behav, October 1, 1999; 26(5): 734 - 750. [Abstract] [PDF]
|
|
|
|
|
|
Committee on Pediatric AIDS and Committee on Infec Issues Related to Human Immunodeficiency Virus Transmission in Schools, Child Care, Medical Settings, the Home, and Community Pediatrics, August 1, 1999; 104(2): 318 - 324. [Abstract] [Full Text]
|
|
|
|
 |
|
 S E Duff, C K M Wong, and R E May Surgeons' and occupational health departments' awareness of guidelines on post-exposure prophylaxis for staff exposed to HIV: telephone survey BMJ, July 17, 1999; 319(7203): 162 - 162. [Full Text]
|
|
|
|
 |
|
 M. Higuchi, A. Fokin, T. N. Masters, F. Robicsek, and G. W. Schmid-Schonbein Transport of colloidal particles in lymphatics and vasculature after subcutaneous injection J Appl Physiol, April 1, 1999; 86(4): 1381 - 1387. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. K. Henderson Postexposure Chemoprophylaxis for Occupational Exposures to the Human Immunodeficiency Virus JAMA, March 10, 1999; 281(10): 931 - 936. [Full Text] [PDF]
|
|
|
|
|
|
P. Lurie, S. Miller, F. Hecht, M. Chesney, and B. Lo Postexposure Prophylaxis After Nonoccupational HIV Exposure: Clinical, Ethical, and Policy Considerations JAMA, November 25, 1998; 280(20): 1769 - 1773. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R A Coutinho HIV and hepatitis C among injecting drug users BMJ, August 15, 1998; 317(7156): 424 - 425. [Full Text]
|
|
|
|
 |
|
 D. M. Cardo, D. H. Culver, C. A. Ciesielski, P. U. Srivastava, R. Marcus, D. Abiteboul, J. Heptonstall, G. Ippolito, F. Lot, P. S. McKibben, et al. A Case-Control Study of HIV Seroconversion in Health Care Workers after Percutaneous Exposure N. Engl. J. Med., November 20, 1997; 337(21): 1485 - 1490. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. D. Pinkerton, D. R. Holtgrave, and H. J. Pinkerton Cost-effectiveness of Chemoprophylaxis After Occupational Exposure to HIV Arch Intern Med, September 22, 1997; 157(17): 1972 - 1980. [Abstract] [PDF]
|
|
|
|
|
|
R. W. Li, J. B. Wong, S. D. Pinkerton, D. R. Holtgrave, F. R. Bloom, M. H. Katz, and J. L. Gerberding Postexposure Treatment of HIV N. Engl. J. Med., August 14, 1997; 337(7): 499 - 501. [Full Text]
|
|
|
|
|
|
M. H. Katz and J. L. Gerberding Postexposure Treatment of People Exposed to the Human Immunodeficiency Virus through Sexual Contact or Injection-Drug Use N. Engl. J. Med., April 10, 1997; 336(15): 1097 - 1100. [Full Text]
|
|
|
|
 |
|
 Major advances in the treatment of HIV-1 infection DTB, April 1, 1997; 35(4): 25 - 29. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Update: Provisional Public Health Service Recommendations for Chemoprophylaxis After Occupational Exposure to HIV JAMA, July 10, 1996; 276(2): 90 - 92. [Abstract] [PDF]
|
|
|
|
|
|
C. C. J. Carpenter, M. A. Fischl, S. M. Hammer, M. S. Hirsch, D. M. Jacobsen, D. A. Katzenstein, J. S. G. Montaner, D. D. Richman, M. S. Saag, R. T. Schooley, et al. Antiretroviral Therapy for HIV Infection in 1996: Recommendations of an International Panel JAMA, July 10, 1996; 276(2): 146 - 154. [Abstract] [PDF]
|
|
|
|
|
|
D. M. DeJoy, R. R. M. Gershon, L. R. Murphy, and M. G. Wilson A Work-Systems Analysis of Compliance With Universal Precautions Among Health Care Workers Health Educ Behav, May 1, 1996; 23(2): 159 - 174. [Abstract] [PDF]
|
|
|
|
 |
|
 Case-Control Study of HIV Seroconversion in Health-Care Workers After Percutaneous Exposure to HIV-Infected Blood--France, United Kingdom, and United States, January 1988-August 1994 Arch Dermatol, March 1, 1996; 132(3): 250 - 252. [Abstract] [PDF]
|
|
|
|
|
|
Case-Control Study of HIV Seroconversion in Health-Care Workers After Percutaneous Exposure to HIV-Infected Blood--France, United Kingdom, and United States, January 1988-August 1994 JAMA, January 24, 1996; 275(4): 274 - 275. [PDF]
|
|
|
|
|
|
G. Forseter, G. P. Wormser, and C. Joline Is Zidovudine a Prophylactic Treatment for Health Care Workers?-Reply Arch Intern Med, September 11, 1995; 155(16): 1816 - 1817. [Abstract] [PDF]
|
|
|
|
|
|
D. N. Gilbert and W. Bennett Patients With Human Immunodeficiency Virus Infection in the Hemodialysis Unit: How Vulnerable Are the Caregivers? Arch Intern Med, August 7, 1995; 155(15): 1575 - 1576. [Abstract] [PDF]
|
|
|
|
|
|
P. L. Kimmel, S. S. VedBrat, P. F. Pierce, W. O. Umana, L. Shepherd, D. A. Verme, R. P. Hirsch, and K. B. Hellman Prevalence of Viremia in Human Immunodeficiency Virus-Infected Patients With Renal Disease Arch Intern Med, August 7, 1995; 155(15): 1578 - 1584. [Abstract] [PDF]
|
|
|
|
|
|
J. L. Gerberding Management of Occupational Exposures to Blood-Borne Viruses N. Engl. J. Med., February 16, 1995; 332(7): 444 - 451. [Full Text] [PDF]
|
|
|
|
|
|
G. Forseter, C. Joline, and G. P. Wormser Tolerability, Safety, and Acceptability of Zidovudine Prophylaxis in Health Care Workers Arch Intern Med, December 12, 1994; 154(23): 2745 - 2749. [Abstract] [PDF]
|
|
|
|
 |
|
 AN UPDATE ON OCCUPATIONAL HIV EXPOSURE Journal Watch (General), July 9, 1993; 1993(709): 1 - 1. [Full Text]
|
|
